EP3830092
Heteróarómatískir NMDA viðtakastillar og notkun á þeim
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
2.8.2019EP published:
3.5.2023EP application number:
19876025.8
EP translation filed:
24.7.2023Grant published:
15.8.2023EPO information:
European Patent Register
Max expiry date:
1.8.2039Expiry date:
1.8.2024
Title in English:
HETEROAROMATIC NMDA RECEPTOR MODULATORS AND USES THEREOFLanguage of the patent:
English
Timeline
Today
2.8.2019EP application
3.5.2023EP Publication
24.7.2023Translation submitted
15.8.2023Registration published
1.8.2024Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
VOLKMANN, Robert, A.Address:
Mystic, CT 06355, US
Name:
ANDERSON, David, R.Address:
Salem, CT 06420, US
Name:
MALEKIANI, SamAddress:
Watertown, MA 02472, US
Name:
PISER, TimothyAddress:
Wilmington, DE 19803, US
Name:
KEANEY, Gregg, F.Address:
Lexington, MA 02421, US
Name:
LEISER, Steven, C.Address:
Valley Cottage, NY 10989, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201862714100 PDate:
3.8.2018Country:
US
Classification
Categories:
C07D 487/04, A61P 25/18
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 12.7.2023
Expires: 1.8.2024
Payer: Árnason Faktor ehf.